Ruping Sun, Zheng Hu, Andrea Sottoriva, Trevor A Graham, Arbel Harpak, Zhicheng Ma, Jared M Fischer, Darryl Shibata, Christina Curtis
Index: 10.1038/ng.3891
Full Text: HTML
Given the implications of tumor dynamics for precision medicine, there is a need to systematically characterize the mode of evolution across diverse solid tumor types. In particular, methods to infer the role of natural selection within established human tumors are lacking. By simulating spatial tumor growth under different evolutionary modes and examining patterns of between-region subclonal genetic divergence from multiregion sequencing (MRS) data, we demonstrate that it is feasible to distinguish tumors driven by strong positive subclonal selection from those evolving neutrally or under weak selection, as the latter fail to dramatically alter subclonal composition. We developed a classifier based on measures of between-region subclonal genetic divergence and projected patient data into model space, finding different modes of evolution both within and between solid tumor types. Our findings have broad implications for how human tumors progress, how they accumulate intratumoral heterogeneity, and ultimately how they may be more effectively treated.
Data models to GO-FAIR
2017-06-28 [10.1038/ng.3910] |
Promoting transcription over long distances
2017-06-28 [10.1038/ng.3904] |
Epigenetic modifier drugs trigger widespread transcription o...
2017-06-28 [10.1038/ng.3902] |
Transposase-driven rearrangements in human tumors
2017-06-28 [10.1038/ng.3908] |
DNMT and HDAC inhibitors induce cryptic transcription start ...
2017-06-12 [10.1038/ng.3889] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved